How do you foster collaboration and innovation in patient access schemes across the industry and academia?
Patient access schemes (PAS) are agreements between healthcare payers and pharmaceutical companies that aim to improve the affordability and availability of innovative medicines for patients. They can take various forms, such as discounts, rebates, risk-sharing, or outcomes-based contracts. However, designing and implementing effective PAS requires collaboration and innovation across the industry and academia, as well as with regulators, clinicians, and patients. In this article, you will learn some best practices and tips on how to foster such collaboration and innovation in PAS.